Evidence map›Paper›PMID 38200282›Full record

ArticleCognitive, affective & behavioral neuroscience2024

Improving preclinical to clinical translation of cognitive function for aging-related disorders: the utility of comprehensive touchscreen testing batteries in common marmosets.

Takeshi Murai, Lauren Bailey, Laura Schultz, Lauren Mongeau, Andrew DeSana, Afonso C Silva, Angela C Roberts, Stacey J Sukoff Rizzo

Open access · hybridAbstract read
In one paragraph

Article in Cognitive, affective & behavioral neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. An open access resource for marmoset neuroscientific apparatus.Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
  7. Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Early molecular events of autosomal-dominant Alzheimer's disease in marmosets with PSEN1 mutations.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Takeshi MuraiAging Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0002-0429-4195
Lauren BaileyAging Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Laura SchultzAging Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Lauren MongeauAging Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Andrew DeSanaAging Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Afonso C SilvaDepartment of Neurobiology, University of Pittsburgh School of Medicine, 514A Bridgeside Point 1, 100 Technology Drive, Pittsburgh, PA, 15219, USA.
Angela C RobertsDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Stacey J Sukoff RizzoAging Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. rizzos@pitt.edu.ORCID 0000-0002-1460-8127
University of Pittsburgh · USUniversity of Cambridge · GB

Funding

Veterinary and Colony Management CoreU19AG074866 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Stacey J Rizzo · 2022 to 2026
$44.9M
Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau SeedingR24AG073190 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SILVA, AFONSO C · 2021 to 2024
$4.5M
NIA NIH HHS R24 AG073190NIA NIH HHS U19 AG074866
6 · The paper itself

Abstract

Concerns about poor animal to human translation have come increasingly to the fore, in particular with regards to cognitive improvements in rodent models, which have failed to translate to meaningful clinical benefit in humans. This problem has been widely acknowledged, most recently in the field of Alzheimer's disease, although this issue pervades the spectrum of central nervous system (CNS) disorders, including neurodevelopmental, neuropsychiatric, and neurodegenerative diseases. Consequently, recent efforts have focused on improving preclinical to clinical translation by incorporating more clinically analogous outcome measures of cognition, such as touchscreen-based assays, which can be employed across species, and have great potential to minimize the translational gap. For aging-related research, it also is important to incorporate model systems that facilitate the study of the long prodromal phase in which cognitive decline begins to emerge and which is a major limitation of short-lived species, such as laboratory rodents. We posit that to improve translation of cognitive function and dysfunction, nonhuman primate models, which have conserved anatomical and functional organization of the primate brain, are necessary to move the field of translational research forward and to bridge the translational gaps. The present studies describe the establishment of a comprehensive battery of touchscreen-based tasks that capture a spectrum of domains sensitive to detecting aging-related cognitive decline, which will provide the greatest benefit through longitudinal evaluation throughout the prolonged lifespan of the marmoset.

Indexed as

AgingCallithrixTranslational Research, BiomedicalAnimalsCognitionCognition DisordersDisease Models, AnimalFemaleMaleNeuropsychological TestsAgingAlzheimer’s diseaseCognitionCognitive flexibilityCommon marmosetsSpatial working memory

Identifiers

PMID38200282
PMCPMC11039501
OpenAlexW4390690609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.